Zachary A Macchi1, Janis Miyasaki1, Maya Katz1, Nicholas Galifianakis1, Stefan Sillau1, Benzi M Kluger1. 1. Department of Neurology (ZAM, SS), and Department of Internal Medicine (ZAM), University of Colorado Anschutz, Aurora; Division of Neurology (JM), Department of Medicine, University of Alberta, Edmonton, Canada; Department of Neurology (MK, NG), University of California San Francisco Medical Center; and Departments of Neurology and Medicine (BMK), University of Rochester Medical Center, NY.
Abstract
OBJECTIVE: To estimate the point prevalence and cumulative incidence of caregiver-reported aggressive behaviors among people living with advanced Parkinson disease and related disorders (PDRDs) and secondarily examine variables associated with aggression. METHODS: Caregivers from a clinical trial of outpatient palliative care for PDRD were surveyed about patient aggression at baseline and every 3 months over 12 months. Baseline responses were used for point prevalence. Cumulative incidence was calculated using responses from caregivers with no reported baseline aggression and available data at all other time points. Measures of disease severity, quality of life, mood, and caregiver burden were included in correlation and relative risk models, adjusting for age, sex, and diagnosis. RESULTS: Of 170 caregivers, 31 (18.2%) reported physical aggression, and 18 (10.6%) reported sexual aggression. Twelve-month cumulative incidence for physical and sexual aggression was 21.1% (23/109) and 16.0% (19/119), respectively. Physical aggression cumulative incidence was associated with patient depression (r = 0.37), patient-perceived quality of life (r = -0.26), caregiver burden (r = 0.26), caregiver-perceived patient quality of life (r = -0.26), and caregiver anxiety (r = 0.20). Age, sex, cognitive impairment, and dementia were not associated with aggression. No variables were associated with cumulative sexual aggression. CONCLUSION: There was a high prevalence and incidence of aggression in our PDRD cohort. This is an understudied issue in PDRD, and our findings highlight the need for increased awareness among neurologists. Providers should consider assessing for aggression when discussing neuropsychiatric symptoms or screening for caregiver burden. Future research should examine the relationship between aggression and patient and caregiver health outcomes. TRIAL REGISTRATION INFORMATION: Clinical trial registration number: NCT02533921.
OBJECTIVE: To estimate the point prevalence and cumulative incidence of caregiver-reported aggressive behaviors among people living with advanced Parkinson disease and related disorders (PDRDs) and secondarily examine variables associated with aggression. METHODS: Caregivers from a clinical trial of outpatient palliative care for PDRD were surveyed about patient aggression at baseline and every 3 months over 12 months. Baseline responses were used for point prevalence. Cumulative incidence was calculated using responses from caregivers with no reported baseline aggression and available data at all other time points. Measures of disease severity, quality of life, mood, and caregiver burden were included in correlation and relative risk models, adjusting for age, sex, and diagnosis. RESULTS: Of 170 caregivers, 31 (18.2%) reported physical aggression, and 18 (10.6%) reported sexual aggression. Twelve-month cumulative incidence for physical and sexual aggression was 21.1% (23/109) and 16.0% (19/119), respectively. Physical aggression cumulative incidence was associated with patient depression (r = 0.37), patient-perceived quality of life (r = -0.26), caregiver burden (r = 0.26), caregiver-perceived patient quality of life (r = -0.26), and caregiver anxiety (r = 0.20). Age, sex, cognitive impairment, and dementia were not associated with aggression. No variables were associated with cumulative sexual aggression. CONCLUSION: There was a high prevalence and incidence of aggression in our PDRD cohort. This is an understudied issue in PDRD, and our findings highlight the need for increased awareness among neurologists. Providers should consider assessing for aggression when discussing neuropsychiatric symptoms or screening for caregiver burden. Future research should examine the relationship between aggression and patient and caregiver health outcomes. TRIAL REGISTRATION INFORMATION: Clinical trial registration number: NCT02533921.
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Benzi M Kluger; Maya Katz; Nicholas Galifianakis; Steven Z Pantilat; Jean S Kutner; Stefan Sillau; Mark Gritz; Jacqueline Jones; Diane Fairclough; Malenna Sumrall; Kirk Hall; Janis Miyasaki Journal: Contemp Clin Trials Date: 2019-02-16 Impact factor: 2.226
Authors: Madeleine Liljegren; Georges Naasan; Julia Temlett; David C Perry; Katherine P Rankin; Jennifer Merrilees; Lea T Grinberg; William W Seeley; Elisabet Englund; Bruce L Miller Journal: JAMA Neurol Date: 2015-03 Impact factor: 18.302
Authors: L Thorgrimsen; A Selwood; A Spector; L Royan; M de Madariaga Lopez; R T Woods; M Orrell Journal: Alzheimer Dis Assoc Disord Date: 2003 Oct-Dec Impact factor: 2.703
Authors: Martijn P G Broen; Nadia E Narayen; Mark L Kuijf; Nadeeka N W Dissanayaka; Albert F G Leentjens Journal: Mov Disord Date: 2016-04-29 Impact factor: 10.338
Authors: Zachary A Macchi; Sandhya Seshadri; Roman Ayele; Meredith Bock; Judith Long; Heather Coats; Janis Miyasaki; Steven Z Pantilat; Maya Katz; Elizabeth J Santos; Stefan H Sillau; Hillary D Lum; Benzi M Kluger Journal: Mov Disord Clin Pract Date: 2022-09-07